Concepedia

Author

Jifeng Feng

Jiangsu Cancer HospitalORCID

Also Known As

Ji-Feng Feng, Ji-feng Feng, Jifeng Feng

57

Publications

1.3K

Citations

14

H-Index

15

Concepts

All Affiliations

Jiangsu Cancer HospitalNanjing Medical UniversitySun Yat-sen UniversitySun Yat-sen University Cancer CenterFudan University Shanghai Cancer Center
JF

About

Jifeng Feng is an author at Jiangsu Cancer Hospital specializing in oncology, pathology, and cancer research.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

2

2

56

2

Pathology

2

2

56

3

Cell Biology

1

1

45

4

Cancer Cell Biology

1

1

45

5

Cancer Genetics

1

1

45

Jifeng Feng

×

17

Publications

1.2K

Citations

14

H-Index

YearCitations

Nivolumab Versus Docetaxel in a Predominantly Chinese Patient Population With Previously Treated Advanced NSCLC: CheckMate 078 Randomized Phase III Clinical Trial

Yi‐Long Wu, Shun Lü, Ying Cheng,

Journal of Thoracic Oncology

2019

347

Pyrotinib or Lapatinib Combined With Capecitabine in HER2–Positive Metastatic Breast Cancer With Prior Taxanes, Anthracyclines, and/or Trastuzumab: A Randomized, Phase II Study

Fei Ma, Quchang Ouyang, Wěi Li,

Journal of Clinical Oncology

2019

335

MSX3 Switches Microglia Polarization and Protects from Inflammation-Induced Demyelination

Zhongwang Yu, Dingya Sun, Jifeng Feng,

Journal of Neuroscience

2015

90

Sintilimab versus docetaxel as second‐line treatment in advanced or metastatic squamous non‐small‐cell lung cancer: an open‐label, randomized controlled phase 3 trial (ORIENT‐3)

Yuankai Shi, Lin Wu, Xinmin Yu,

Cancer Communications

2022

53

Rosmarinic acid reduces the resistance of gastric carcinoma cells to 5-fluorouracil by downregulating FOXO4-targeting miR-6785-5p

Yu Chen, Dongqing Chen, Haixia Liu,

Biomedicine & Pharmacotherapy

2018

51

Plasma Hemopexin ameliorates murine spinal cord injury by switching microglia from the M1 state to the M2 state

Dunxin Han, Zhongwang Yu, Weili Liu,

Cell Death and Disease

2018

49

MicroRNA-106b-5p regulates cisplatin chemosensitivity by targeting polycystic kidney disease-2 in non-small-cell lung cancer

Shaorong Yu, Xiaobing Qin, Tingting Chen,

Anti-Cancer Drugs

2017

45

Reversal of multidrug resistance by cisplatin-loaded magnetic Fe3O4 nanoparticles in A549/DDP lung cancer cells in vitro and in vivo

Baoan Chen, Ke Li, Guohua Xia,

International Journal of Nanomedicine

2013

43

Platinum‐based chemotherapy plus cetuximab first‐line for Asian patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck: Results of an open‐label, single‐arm, multicenter trial

Ye Guo, Mei Shi, Ankui Yang,

Head & Neck

2014

32

miR-4319 Suppresses the Growth of Esophageal Squamous Cell Carcinoma Via Targeting NLRC5

Xiao Hu, Min Wang, Lei Cao,

Current Molecular Pharmacology

2019

26

Page 1